CAPECITABINE

CAPECITABINE was reported 92086 times

These side effects are most commonly reported by patients taking CAPECITABINE:

# Side effect Count
0 DIARRHOEA 13789
1 DEATH 8917
2 NAUSEA 8547
3 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 6732
4 FATIGUE 6570
5 VOMITING 6344
6 DISEASE PROGRESSION 6113
7 MALIGNANT NEOPLASM PROGRESSION 4033
8 OFF LABEL USE 3895
9 ASTHENIA 3451
10 DECREASED APPETITE 3316
11 NEUTROPENIA 3161
12 NEUROPATHY PERIPHERAL 2958
13 DEHYDRATION 2767
14 DYSPNOEA 2695
15 DRUG INEFFECTIVE 2654
16 THROMBOCYTOPENIA 2573
17 PYREXIA 2495
18 ANAEMIA 2428
19 ABDOMINAL PAIN 2291
20 RASH 2282
21 PAIN 2212
22 STOMATITIS 2127
23 WEIGHT DECREASED 2069
24 MUCOSAL INFLAMMATION 2012
25 CONSTIPATION 1902
26 METASTASES TO LIVER 1863
27 MALAISE 1792
28 PAIN IN EXTREMITY 1778
29 DIZZINESS 1647
30 HEADACHE 1588
31 PARAESTHESIA 1554
32 ERYTHEMA 1486
33 MYELOSUPPRESSION 1386
34 PNEUMONIA 1375
35 NEOPLASM PROGRESSION 1363
36 METASTASES TO BONE 1336
37 PLATELET COUNT DECREASED 1328
38 HYPOAESTHESIA 1276
39 BREAST CANCER METASTATIC 1248
40 SEPSIS 1239
41 SKIN EXFOLIATION 1213
42 DRY SKIN 1201
43 GENERAL PHYSICAL HEALTH DETERIORATION 1190
44 FEBRILE NEUTROPENIA 1188
45 WHITE BLOOD CELL COUNT DECREASED 1179
46 LEUKOPENIA 1164
47 HYPERTENSION 1153
48 ABDOMINAL PAIN UPPER 1147
49 CHEST PAIN 1131
50 PULMONARY EMBOLISM 1104
51 BACK PAIN 1088
52 METASTASES TO CENTRAL NERVOUS SYSTEM 1082
53 TOXICITY TO VARIOUS AGENTS 1054
54 COUGH 1050
55 HYPOKALAEMIA 1048
56 METASTASES TO LUNG 1037
57 PLEURAL EFFUSION 980
58 ALOPECIA 972
59 BREAST CANCER 964
60 FALL 951
61 INFECTION 950
62 DYSPHAGIA 937
63 HYPOTENSION 934
64 ARTHRALGIA 925
65 PRURITUS 924
66 SKIN DISCOLOURATION 887
67 THERAPY INTERRUPTED 841
68 ASCITES 819
69 NEUROTOXICITY 809
70 OEDEMA PERIPHERAL 793
71 PERIPHERAL SWELLING 763
72 URINARY TRACT INFECTION 757
73 RENAL FAILURE 754
74 HOSPITALISATION 751
75 MUSCLE SPASMS 730
76 BONE MARROW FAILURE 724
77 DRUG INTOLERANCE 711
78 INTENTIONAL PRODUCT USE ISSUE 711
79 GASTROINTESTINAL DISORDER 703
80 GAIT DISTURBANCE 700
81 ACUTE KIDNEY INJURY 691
82 PANCYTOPENIA 690
83 NO ADVERSE EVENT 686
84 HYPERSENSITIVITY 685
85 THROMBOSIS 683
86 BLOOD BILIRUBIN INCREASED 680
87 ABDOMINAL DISTENSION 677
88 COLITIS 676
89 INTESTINAL OBSTRUCTION 676
90 HEPATIC FUNCTION ABNORMAL 670
91 INSOMNIA 669
92 PRODUCT USE IN UNAPPROVED INDICATION 663
93 HAEMOGLOBIN DECREASED 659
94 BLISTER 654
95 EPISTAXIS 654
96 NEUTROPHIL COUNT DECREASED 650
97 CONFUSIONAL STATE 626
98 CHILLS 624
99 SKIN FISSURES 616
100 ABDOMINAL DISCOMFORT 614
101 ALANINE AMINOTRANSFERASE INCREASED 597
102 ASPARTATE AMINOTRANSFERASE INCREASED 597
103 DEEP VEIN THROMBOSIS 597
104 ARTERIOSPASM CORONARY 593
105 ANXIETY 591
106 THERAPY CESSATION 565
107 RENAL IMPAIRMENT 553
108 METASTASES TO LYMPH NODES 551
109 DYSPEPSIA 549
110 HAEMORRHAGE 548
111 DRUG INTERACTION 539
112 GASTROINTESTINAL TOXICITY 524
113 OSTEONECROSIS OF JAW 521
114 CARDIAC ARREST 520
115 BONE PAIN 505
116 CONDITION AGGRAVATED 488
117 INTERSTITIAL LUNG DISEASE 488
118 ENTERITIS 487
119 NEOPLASM MALIGNANT 487
120 SOMNOLENCE 481
121 MYALGIA 479
122 THERAPY PARTIAL RESPONDER 478
123 HYPONATRAEMIA 472
124 GASTROINTESTINAL HAEMORRHAGE 468
125 CEREBROVASCULAR ACCIDENT 467
126 BLOOD CREATININE INCREASED 466
127 BLOOD PRESSURE INCREASED 466
128 HAEMATOTOXICITY 466
129 RESPIRATORY FAILURE 466
130 ILL-DEFINED DISORDER 462
131 SYNCOPE 459
132 CARDIOTOXICITY 457
133 NASOPHARYNGITIS 457
134 MYOCARDIAL INFARCTION 456
135 DYSGEUSIA 455
136 TACHYCARDIA 453
137 HEPATIC FAILURE 452
138 BURNING SENSATION 446
139 MUSCULAR WEAKNESS 445
140 SEPTIC SHOCK 439
141 SKIN TOXICITY 426
142 TREMOR 424
143 WEIGHT INCREASED 420
144 ATRIAL FIBRILLATION 419
145 PNEUMONITIS 419
146 HYPERBILIRUBINAEMIA 413
147 CARDIAC FAILURE 411
148 EJECTION FRACTION DECREASED 402
149 HEPATIC ENZYME INCREASED 400
150 ENTEROCOLITIS 397
151 MOUTH ULCERATION 393
152 FEELING ABNORMAL 390
153 CHEST DISCOMFORT 389
154 DEPRESSION 389
155 LYMPHADENOPATHY 388
156 PROTEINURIA 387
157 JAUNDICE 379
158 METASTASIS 373
159 HOSPICE CARE 372
160 PULMONARY OEDEMA 366
161 DRY MOUTH 365
162 GASTROOESOPHAGEAL REFLUX DISEASE 365
163 COVID-19 364
164 LIVER DISORDER 364
165 INFUSION RELATED REACTION 359
166 LOSS OF CONSCIOUSNESS 356
167 BLOOD POTASSIUM DECREASED 355
168 TUMOUR MARKER INCREASED 351
169 BALANCE DISORDER 350
170 LETHARGY 350
171 PALPITATIONS 344
172 ILEUS 342
173 HYPERGLYCAEMIA 340
174 OEDEMA 338
175 SEIZURE 338
176 HEPATOTOXICITY 334
177 MEMORY IMPAIRMENT 332
178 CARDIAC DISORDER 327
179 VISION BLURRED 327
180 ORAL PAIN 326
181 PRODUCT DOSE OMISSION ISSUE 323
182 BLOOD ALKALINE PHOSPHATASE INCREASED 321
183 DISEASE RECURRENCE 321
184 NAIL DISORDER 321
185 BLOOD PRESSURE DECREASED 319
186 OSTEONECROSIS 318
187 POLYNEUROPATHY 318
188 SWELLING 315
189 DRUG HYPERSENSITIVITY 311
190 DYSPHONIA 310
191 RENAL FAILURE ACUTE 307
192 IMPAIRED HEALING 305
193 PARONYCHIA 305
194 VISUAL IMPAIRMENT 299
195 ANGINA PECTORIS 293
196 FLATULENCE 293
197 HYPOALBUMINAEMIA 293
198 RECTAL HAEMORRHAGE 293
199 PAIN IN JAW 292
200 PERICARDIAL EFFUSION 290
201 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 289
202 SKIN DISORDER 288
203 LACRIMATION INCREASED 287
204 CONTUSION 283
205 PERIPHERAL SENSORY NEUROPATHY 282
206 VENTRICULAR FIBRILLATION 280
207 C-REACTIVE PROTEIN INCREASED 279
208 ADVERSE DRUG REACTION 277
209 CELLULITIS 277
210 SMALL INTESTINAL OBSTRUCTION 275
211 PRODUCT USE ISSUE 274
212 PULMONARY MASS 274
213 OROPHARYNGEAL PAIN 273
214 TREATMENT FAILURE 270
215 HYPOPHAGIA 269
216 HYPERHIDROSIS 268
217 HEART RATE INCREASED 266
218 LIVER INJURY 266
219 INTESTINAL PERFORATION 264
220 ELECTROLYTE IMBALANCE 259
221 BONE DISORDER 256
222 UNEVALUABLE EVENT 256
223 INFLAMMATION 254
224 SKIN ULCER 251
225 FLUSHING 250
226 TRANSAMINASES INCREASED 250
227 BLOOD GLUCOSE INCREASED 249
228 GAMMA-GLUTAMYLTRANSFERASE INCREASED 248
229 METASTASES TO PERITONEUM 248
230 GASTRITIS 245
231 MUSCULOSKELETAL PAIN 245
232 RED BLOOD CELL COUNT DECREASED 245
233 DYSURIA 244
234 SPEECH DISORDER 244
235 DRUG-INDUCED LIVER INJURY 243
236 NEOPLASM 241
237 DISSEMINATED INTRAVASCULAR COAGULATION 240
238 DYSARTHRIA 240
239 GASTROINTESTINAL PERFORATION 240
240 HYPOCALCAEMIA 239
241 HAEMATEMESIS 236
242 ACUTE MYOCARDIAL INFARCTION 233
243 OESOPHAGITIS 229
244 HAEMATOCHEZIA 227
245 ARRHYTHMIA 225
246 COLON CANCER 225
247 METASTASES TO SPINE 225
248 ILLNESS 224
249 NEUTROPENIC SEPSIS 223
250 HEPATIC LESION 222
251 DIABETES MELLITUS 216
252 MULTIPLE ORGAN DYSFUNCTION SYNDROME 216
253 EPILEPSY 214
254 CONVULSION 213
255 DERMATITIS 213
256 METASTATIC NEOPLASM 213
257 URTICARIA 213
258 TEMPERATURE INTOLERANCE 211
259 CEREBRAL INFARCTION 207
260 LUNG DISORDER 207
261 HERPES ZOSTER 204
262 CARCINOEMBRYONIC ANTIGEN INCREASED 201
263 DYSPNOEA EXERTIONAL 201
264 HOT FLUSH 199
265 HYPOGLYCAEMIA 199
266 PERITONITIS 199
267 METABOLIC ACIDOSIS 197
268 DRUG RESISTANCE 196
269 HYPOMAGNESAEMIA 196
270 RHINORRHOEA 196
271 DRY EYE 195
272 HICCUPS 195
273 JOINT SWELLING 195
274 VERTIGO 195
275 BLOOD LACTATE DEHYDROGENASE INCREASED 192
276 HYPERAESTHESIA 192
277 CHOLESTASIS 190
278 FEELING HOT 190
279 HYPOXIA 190
280 BREAST CANCER RECURRENT 189
281 HEPATIC STEATOSIS 189
282 OSTEOMYELITIS 188
283 PANCREATITIS 187
284 BRAIN OEDEMA 185
285 COMA 185
286 HAEMATURIA 185
287 CEREBRAL HAEMORRHAGE 183
288 EMBOLISM 183
289 SURGERY 183
290 ANAPHYLACTIC REACTION 182
291 CARDIO-RESPIRATORY ARREST 182
292 COAGULOPATHY 182
293 OVERDOSE 182
294 TASTE DISORDER 182
295 TRANSIENT ISCHAEMIC ATTACK 182
296 NECK PAIN 181
297 EATING DISORDER 179
298 HYPOTHYROIDISM 179
299 CIRCULATORY COLLAPSE 178
300 DERMATITIS ACNEIFORM 178
301 SINUSITIS 178
302 SLEEP DISORDER 178
303 WHITE BLOOD CELL COUNT INCREASED 178
304 FEELING COLD 177
305 SKIN REACTION 177
306 CANDIDA INFECTION 176
307 CHOLELITHIASIS 176
308 LARYNGOSPASM 176
309 METASTASES TO SKIN 176
310 SWELLING FACE 176
311 SKIN LESION 174
312 COLORECTAL CANCER METASTATIC 172
313 HYPERKALAEMIA 172
314 SKIN HYPERPIGMENTATION 172
315 DISCOMFORT 171
316 HYPERTRIGLYCERIDAEMIA 171
317 LIVER FUNCTION TEST ABNORMAL 171
318 LYMPHOEDEMA 171
319 AMNESIA 170
320 ATELECTASIS 170
321 PNEUMOTHORAX 170
322 THERAPY NON-RESPONDER 170
323 ACNE 169
324 ANOREXIA 169
325 DEPRESSED MOOD 169
326 UPPER RESPIRATORY TRACT INFECTION 169
327 RENAL DISORDER 168
328 TOOTHACHE 168
329 ACUTE CORONARY SYNDROME 166
330 MULTI-ORGAN FAILURE 166
331 BLOOD ALBUMIN DECREASED 164
332 PORTAL HYPERTENSION 164
333 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 163
334 FEEDING DISORDER 162
335 ADVERSE EVENT 161
336 MUSCULOSKELETAL STIFFNESS 161
337 ACUTE MYELOID LEUKAEMIA 160
338 BONE LESION 160
339 CARDIAC FAILURE CONGESTIVE 159
340 STRESS 159
341 THERAPEUTIC RESPONSE DECREASED 159
342 CYSTITIS 158
343 GINGIVAL BLEEDING 158
344 URINARY RETENTION 158
345 MALNUTRITION 157
346 RASH PRURITIC 156
347 DIPLOPIA 155
348 LIVER FUNCTION TEST INCREASED 155
349 PNEUMONIA ASPIRATION 155
350 DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY 154
351 BLOOD SODIUM DECREASED 152
352 MYOCARDIAL ISCHAEMIA 152
353 NEURALGIA 152
354 ELECTROCARDIOGRAM QT PROLONGED 151
355 RECURRENT CANCER 150
356 MASS 149
357 RASH ERYTHEMATOUS 149
358 BLOOD MAGNESIUM DECREASED 148
359 LEFT VENTRICULAR DYSFUNCTION 148
360 MUSCULOSKELETAL CHEST PAIN 148
361 PRODUCTIVE COUGH 148
362 SUDDEN DEATH 148
363 THERAPY CHANGE 148
364 ECZEMA 147
365 ONYCHOMADESIS 147
366 HYPOVOLAEMIC SHOCK 146
367 OXYGEN SATURATION DECREASED 146
368 BRONCHITIS 144
369 PANCREATIC CARCINOMA 144
370 VENOOCCLUSIVE LIVER DISEASE 144
371 HYDRONEPHROSIS 143
372 CARDIOGENIC SHOCK 142
373 DISORIENTATION 142
374 MENTAL STATUS CHANGES 142
375 GASTROENTERITIS 141
376 HEMIPARESIS 141
377 HEPATIC CYTOLYSIS 141
378 LARGE INTESTINE PERFORATION 141
379 METASTASES TO PLEURA 141
380 TOOTH EXTRACTION 141
381 BACTERAEMIA 140
382 COLON CANCER METASTATIC 140
383 LYMPHOPENIA 140
384 HAEMATOCRIT DECREASED 139
385 HAEMORRHOIDS 139
386 HEPATITIS 139
387 CARDIOMYOPATHY 138
388 DEVICE RELATED INFECTION 138
389 GAIT INABILITY 138
390 NERVOUS SYSTEM DISORDER 138
391 SHOCK 137
392 CENTRAL NERVOUS SYSTEM LESION 136
393 ANASTOMOTIC LEAK 135
394 INJECTION SITE PAIN 135
395 INTERNATIONAL NORMALISED RATIO INCREASED 135
396 RETCHING 135
397 SECOND PRIMARY MALIGNANCY 135
398 LEUKOCYTOSIS 134
399 PIGMENTATION DISORDER 134
400 ENCEPHALOPATHY 133
401 FREQUENT BOWEL MOVEMENTS 133
402 INFLUENZA 133
403 MOBILITY DECREASED 133
404 PROCTALGIA 133
405 BRAIN NEOPLASM 132
406 HEART RATE DECREASED 132
407 DELIRIUM 131
408 BODY TEMPERATURE DECREASED 130
409 INCORRECT DOSE ADMINISTERED 130
410 MEDICATION ERROR 130
411 METASTASES TO MENINGES 130
412 TENDERNESS 130
413 TOOTH DISORDER 130
414 LIP SWELLING 129
415 LOWER RESPIRATORY TRACT INFECTION 129
416 BLOOD UREA INCREASED 128
417 FAECES DISCOLOURED 128
418 WOUND 128
419 ATAXIA 127
420 DEPRESSED LEVEL OF CONSCIOUSNESS 127
421 CATARACT 126
422 FISTULA 126
423 INFLUENZA LIKE ILLNESS 126
424 HEPATIC CIRRHOSIS 125
425 CHOLANGITIS 124
426 FLUID RETENTION 124
427 HAEMOPTYSIS 124
428 LEUKOENCEPHALOPATHY 124
429 NEPHROLITHIASIS 124
430 APHASIA 123
431 BLINDNESS 123
432 BLOOD TEST ABNORMAL 123
433 COGNITIVE DISORDER 123
434 FULL BLOOD COUNT DECREASED 123
435 INJURY 123
436 PERFORMANCE STATUS DECREASED 123
437 SPLENOMEGALY 123
438 ABSCESS 122
439 MYELODYSPLASTIC SYNDROME 122
440 POLLAKIURIA 122
441 GASTRIC DISORDER 121
442 SENSORY DISTURBANCE 121
443 INVASIVE DUCTAL BREAST CARCINOMA 120
444 LOCALISED INFECTION 120
445 CONJUNCTIVITIS 119
446 NIGHT SWEATS 119
447 ONYCHOLYSIS 119
448 HEPATOCELLULAR INJURY 118
449 CHEILITIS 117
450 HYPOPHOSPHATAEMIA 117
451 RASH MACULO-PAPULAR 117
452 AGRANULOCYTOSIS 116
453 GASTRIC CANCER 116
454 LIMB DISCOMFORT 116
455 MELAENA 116
456 PANCREATITIS ACUTE 116
457 PERIPHERAL COLDNESS 116
458 VISUAL ACUITY REDUCED 116
459 ARTHRITIS 115
460 PIK3CA-ACTIVATED MUTATION 115
461 BRONCHOSPASM 114
462 CACHEXIA 114
463 GASTROINTESTINAL INFLAMMATION 114
464 HALLUCINATION 114
465 ONYCHOCLASIS 114
466 THROAT TIGHTNESS 114
467 CLOSTRIDIUM DIFFICILE INFECTION 113
468 INTESTINAL ISCHAEMIA 113
469 RADIATION SKIN INJURY 113
470 ALTERED STATE OF CONSCIOUSNESS 112
471 CHOLECYSTITIS 112
472 ASTHMA 111
473 PROCTITIS 111
474 PULMONARY THROMBOSIS 111
475 ABASIA 110
476 EYE IRRITATION 110
477 RASH MACULAR 110
478 STEVENS-JOHNSON SYNDROME 110
479 UNDERDOSE 110
480 DRUG DOSE OMISSION 109
481 PULMONARY FIBROSIS 109
482 THROAT IRRITATION 109
483 MIGRAINE 108
484 ULCER 108
485 UPPER GASTROINTESTINAL HAEMORRHAGE 108
486 BLOOD CALCIUM DECREASED 107
487 RESPIRATORY DISTRESS 107
488 WHEEZING 107
489 ACUTE RESPIRATORY DISTRESS SYNDROME 106
490 RIB FRACTURE 106
491 STAPHYLOCOCCAL INFECTION 106
492 WOUND DEHISCENCE 106
493 DRUG TOXICITY 105
494 ISCHAEMIC STROKE 105
495 OSTEOARTHRITIS 105
496 URINARY INCONTINENCE 105
497 ABDOMINAL PAIN LOWER 104
498 BODY TEMPERATURE INCREASED 104
499 DEAFNESS 104
500 HYPERCALCAEMIA 104
501 SPINAL PAIN 104
502 CARBOHYDRATE ANTIGEN 15-3 INCREASED 103
503 VARICES OESOPHAGEAL 103
504 BLOOD CREATINE PHOSPHOKINASE INCREASED 102
505 GASTRIC ULCER 102
506 HAEMOLYTIC ANAEMIA 102
507 HYPERSOMNIA 102
508 HYPOAESTHESIA ORAL 102
509 ILEUS PARALYTIC 102
510 ORAL DISORDER 102
511 THROMBOTIC MICROANGIOPATHY 101
512 AGITATION 100
513 BREAST CANCER FEMALE 100
514 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 100
515 DIARRHOEA HAEMORRHAGIC 100
516 ODYNOPHAGIA 100
517 PAIN OF SKIN 100
518 SWOLLEN TONGUE 100
519 GASTRIC PERFORATION 99
520 MITRAL VALVE INCOMPETENCE 99
521 AGEUSIA 98
522 MOVEMENT DISORDER 98
523 FEMUR FRACTURE 97
524 ORAL CANDIDIASIS 97
525 ORAL HERPES 97
526 HIP FRACTURE 96
527 LOCAL SWELLING 96
528 NAIL DISCOLOURATION 96
529 PALLOR 96
530 ARTHROPATHY 95
531 BRADYCARDIA 95
532 CHROMATURIA 95
533 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 95
534 HEPATIC NEOPLASM 95
535 LABORATORY TEST ABNORMAL 95
536 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 95
537 SINUS TACHYCARDIA 95
538 TINNITUS 95
539 PELVIC PAIN 94
540 VASCULAR DEVICE INFECTION 94
541 WOUND INFECTION 94
542 BACTERIAL INFECTION 93
543 COMPUTERISED TOMOGRAM ABNORMAL 93
544 HEPATIC ENCEPHALOPATHY 93
545 NEOPLASM RECURRENCE 93
546 RESTLESSNESS 93
547 AZOTAEMIA 92
548 BLOOD URINE PRESENT 92
549 DIABETIC KETOACIDOSIS 92
550 DYSAESTHESIA 92
551 HYPERTRANSAMINASAEMIA 92
552 PERIPHERAL ISCHAEMIA 92
553 STRESS CARDIOMYOPATHY 92
554 EMOTIONAL DISTRESS 91
555 SKIN BURNING SENSATION 91
556 CYTOPENIA 90
557 FRACTURE 90
558 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 90
559 LUNG INFILTRATION 90
560 RESPIRATORY DISORDER 90
561 ARTERIOSCLEROSIS CORONARY ARTERY 89
562 HYPOVOLAEMIA 89
563 PATHOLOGICAL FRACTURE 89
564 SUBILEUS 89
565 ROAD TRAFFIC ACCIDENT 88
566 HEPATIC CANCER 87
567 HYPERLIPIDAEMIA 87
568 INTERVERTEBRAL DISC PROTRUSION 86
569 LIVER ABSCESS 86
570 MUSCLE TWITCHING 86
571 VENTRICULAR TACHYCARDIA 86
572 FUNGAL INFECTION 85
573 HEPATOMEGALY 85
574 ORAL MUCOSAL BLISTERING 85
575 SPINAL OSTEOARTHRITIS 85
576 EYE PAIN 84
577 GINGIVAL PAIN 84
578 DUODENAL ULCER 83
579 HYPERAMMONAEMIC ENCEPHALOPATHY 83
580 RECTAL CANCER 83
581 UNRESPONSIVE TO STIMULI 83
582 BLOOD CHOLESTEROL INCREASED 82
583 EAR PAIN 82
584 EYE DISORDER 82
585 HEAD INJURY 82
586 LYMPHOCYTE COUNT DECREASED 82
587 RHABDOMYOLYSIS 82
588 TOOTH LOSS 82
589 DIVERTICULITIS 81
590 HEART RATE IRREGULAR 81
591 LUNG NEOPLASM 81
592 NEPHROTIC SYNDROME 81
593 ORAL DISCOMFORT 81
594 SKIN CHAPPED 81
595 BREAST PAIN 80
596 HYPERAMMONAEMIA 80
597 LUNG NEOPLASM MALIGNANT 80
598 ORTHOSTATIC HYPOTENSION 80
599 OSTEOSCLEROSIS 80
600 PNEUMATOSIS INTESTINALIS 80
601 DEVICE OCCLUSION 79
602 ERUCTATION 79
603 INCONTINENCE 79
604 ADENOCARCINOMA 78
605 COLITIS ISCHAEMIC 78
606 DYSSTASIA 78
607 PORTAL VEIN THROMBOSIS 78
608 ACUTE RESPIRATORY FAILURE 77
609 ADENOCARCINOMA OF COLON 77
610 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 77
611 JOINT STIFFNESS 77
612 LYMPHANGIOSIS CARCINOMATOSA 77
613 OSTEOPOROSIS 77
614 PULMONARY TOXICITY 77
615 RESPIRATORY TRACT INFECTION 77
616 TRICUSPID VALVE INCOMPETENCE 77
617 TUMOUR PERFORATION 77
618 DRUG EFFECT DECREASED 76
619 EXPOSED BONE IN JAW 76
620 OSTEOLYSIS 76
621 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 76
622 TOOTH ABSCESS 76
623 COLORECTAL CANCER 75
624 FAECES SOFT 75
625 GINGIVITIS 75
626 NEUTROPENIC COLITIS 75
627 PARAESTHESIA ORAL 75
628 STRIDOR 75
629 TREATMENT NONCOMPLIANCE 75
630 VENOUS THROMBOSIS 75
631 APHTHOUS ULCER 74
632 FINGERPRINT LOSS 74
633 GASTROINTESTINAL INJURY 74
634 NEPHROPATHY TOXIC 74
635 NEUTROPHIL COUNT INCREASED 74
636 SENSORY LOSS 74
637 WEIGHT FLUCTUATION 74
638 EMOTIONAL DISORDER 73
639 HYPERTENSIVE CRISIS 73
640 ISCHAEMIA 73
641 MYOCARDITIS 73
642 NO THERAPEUTIC RESPONSE 73
643 PSEUDOCIRRHOSIS 73
644 DENTAL CARIES 72
645 MUSCULOSKELETAL DISORDER 72
646 OCULAR HYPERAEMIA 72
647 PANCREATIC CARCINOMA METASTATIC 72
648 PERICARDITIS 72
649 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 72
650 CARDIOMEGALY 71
651 EYELID PTOSIS 71
652 NAIL INFECTION 71
653 ANGIOEDEMA 70
654 HAEMOLYSIS 70
655 HEPATIC CYST 70
656 HIATUS HERNIA 70
657 JAUNDICE CHOLESTATIC 70
658 MENTAL DISORDER 70
659 METASTASES TO ADRENALS 70
660 PROTHROMBIN TIME PROLONGED 70
661 BLOOD CREATININE DECREASED 69
662 BLOOD DISORDER 69
663 BLOOD PRESSURE DIASTOLIC DECREASED 69
664 IMMUNODEFICIENCY 69
665 IRON DEFICIENCY ANAEMIA 69
666 PRESYNCOPE 69
667 PULMONARY HYPERTENSION 69
668 BLOOD PRESSURE SYSTOLIC INCREASED 68
669 EMBOLISM VENOUS 68
670 PLATELET COUNT INCREASED 68
671 ADRENAL INSUFFICIENCY 67
672 ASPIRATION 67
673 BILE DUCT OBSTRUCTION 67
674 HEPATIC MASS 67
675 IMPAIRED GASTRIC EMPTYING 67
676 INTENTIONAL PRODUCT MISUSE 67
677 POST PROCEDURAL COMPLICATION 67
678 STREPTOCOCCAL SEPSIS 67
679 TACHYPNOEA 67
680 INJECTION SITE ERYTHEMA 66
681 NECROTISING FASCIITIS 66
682 PHOTOSENSITIVITY REACTION 66
683 TROPONIN INCREASED 66
684 UROSEPSIS 66
685 COMPRESSION FRACTURE 65
686 CROHN^S DISEASE 65
687 GASTRIC HAEMORRHAGE 65
688 HIP ARTHROPLASTY 65
689 IMMUNE SYSTEM DISORDER 65
690 METASTASES TO THE MEDIASTINUM 65
691 RASH GENERALISED 65
692 VAGINAL HAEMORRHAGE 65
693 ACUTE PROMYELOCYTIC LEUKAEMIA 64
694 ARTERIAL THROMBOSIS 64
695 CEREBRAL ISCHAEMIA 64
696 CLOSTRIDIUM DIFFICILE COLITIS 64
697 CONGESTIVE CARDIOMYOPATHY 64
698 DECUBITUS ULCER 64
699 DISTURBANCE IN ATTENTION 64
700 GLOSSODYNIA 64
701 MALIGNANT PLEURAL EFFUSION 64
702 MOUTH HAEMORRHAGE 64
703 NODULE 64
704 TOOTH FRACTURE 64
705 TYPE 2 DIABETES MELLITUS 64
706 BLOOD GLUCOSE DECREASED 63
707 EYE SWELLING 63
708 GASTROINTESTINAL PAIN 63
709 HAEMATOMA 63
710 HYPOACUSIS 63
711 IRRITABILITY 63
712 MUSCLE ATROPHY 63
713 PURULENT DISCHARGE 63
714 TONGUE DISCOLOURATION 63
715 TUMOUR PAIN 63
716 COLITIS ULCERATIVE 62
717 FAILURE TO THRIVE 62
718 FLANK PAIN 62
719 GASTROINTESTINAL INFECTION 62
720 HAEMOGLOBIN ABNORMAL 62
721 HYPERCHOLESTEROLAEMIA 62
722 MYOSITIS 62
723 RENAL CYST 62
724 CLOSTRIDIAL INFECTION 61
725 CORONARY ARTERY DISEASE 61
726 HYPERKERATOSIS 61
727 LYMPHADENOPATHY MEDIASTINAL 61
728 PROTEIN TOTAL DECREASED 61
729 RECALL PHENOMENON 61
730 RETINAL DETACHMENT 61
731 SKIN IRRITATION 61
732 TERMINAL ILEITIS 61
733 ANGINA UNSTABLE 60
734 BONE MARROW TOXICITY 60
735 DYSCHEZIA 60
736 IMPAIRED QUALITY OF LIFE 60
737 LIMB INJURY 60
738 NASAL CONGESTION 60
739 OSTEOPENIA 60
740 PRODUCT QUALITY ISSUE 60
741 SPINAL FRACTURE 60
742 TUMOUR HAEMORRHAGE 60
743 ANAL INCONTINENCE 59
744 BLOOD POTASSIUM INCREASED 59
745 BREAST DISORDER 59
746 CARDIAC FAILURE ACUTE 59
747 COLD SWEAT 59
748 DRUG ERUPTION 59
749 GENERALISED OEDEMA 59
750 GRANULOCYTE COUNT DECREASED 59
751 NEUTROPHIL COUNT ABNORMAL 59
752 PERIPHERAL MOTOR NEUROPATHY 59
753 PRODUCT DOSE OMISSION IN ERROR 59
754 TRISMUS 59
755 ANASTOMOTIC COMPLICATION 58
756 BREAST MASS 58
757 FACE OEDEMA 58
758 FOOT FRACTURE 58
759 LUNG INFECTION 58
760 NEEDLE ISSUE 58
761 PARALYSIS 58
762 PERIODONTITIS 58
763 PSEUDOMONAL SEPSIS 58
764 ANAPHYLACTIC SHOCK 57
765 CANCER PAIN 57
766 INGROWING NAIL 57
767 LIPASE INCREASED 57
768 METABOLIC DISORDER 57
769 NON-CIRRHOTIC PORTAL HYPERTENSION 57
770 PHARYNGITIS 57
771 PRIMARY SEQUESTRUM 57
772 RASH PUSTULAR 57
773 VARICOSE VEIN 57
774 VIRAL INFECTION 57
775 AORTIC DISSECTION 56
776 ASTHENOPIA 56
777 BLOOD COUNT ABNORMAL 56
778 COORDINATION ABNORMAL 56
779 DYSAESTHESIA PHARYNX 56
780 IMMUNOSUPPRESSION 56
781 KLEBSIELLA INFECTION 56
782 LEFT VENTRICULAR FAILURE 56
783 RESPIRATORY ARREST 56
784 TOXIC SKIN ERUPTION 56
785 APHONIA 55
786 GASTROINTESTINAL NECROSIS 55
787 NECROSIS 55
788 SKIN HAEMORRHAGE 55
789 SNEEZING 55
790 FAECALOMA 54
791 GRANULOCYTOPENIA 54
792 HER2 POSITIVE BREAST CANCER 54
793 RENAL INJURY 54
794 THERMAL BURN 54
795 TONGUE DISORDER 54
796 ABDOMINAL LYMPHADENOPATHY 53
797 ACIDOSIS 53
798 ADVERSE REACTION 53
799 EYE PRURITUS 53
800 GASTROINTESTINAL ANASTOMOTIC LEAK 53
801 HEMIPLEGIA 53
802 INTRACRANIAL PRESSURE INCREASED 53
803 LARGE INTESTINAL OBSTRUCTION 53
804 NAIL BED INFLAMMATION 53
805 OBSTRUCTION GASTRIC 53
806 ORAL INTAKE REDUCED 53
807 PALMAR ERYTHEMA 53
808 SMALL INTESTINAL PERFORATION 53
809 TOXIC EPIDERMAL NECROLYSIS 53
810 DEVICE RELATED THROMBOSIS 52
811 INTERVERTEBRAL DISC DEGENERATION 52
812 OESOPHAGEAL STENOSIS 52
813 PANCREATIC NEUROENDOCRINE TUMOUR 52
814 PHOTOPHOBIA 52
815 ACCIDENTAL OVERDOSE 51
816 CARDIAC TAMPONADE 51
817 CRYING 51
818 GASTROINTESTINAL STOMA COMPLICATION 51
819 HYPERTHERMIA 51
820 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 51
821 JAW DISORDER 51
822 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 51
823 RED CELL DISTRIBUTION WIDTH INCREASED 51
824 SKIN MASS 51
825 THIRST 51
826 TOOTH INFECTION 51
827 ANHEDONIA 50
828 BLOOD IRON DECREASED 50
829 BLOOD LACTIC ACID INCREASED 50
830 CYANOSIS 50
831 HEPATIC PAIN 50
832 INJECTION SITE SWELLING 50
833 METASTASES TO CHEST WALL 50
834 PHLEBITIS 50
835 PRINZMETAL ANGINA 50
836 SCIATICA 50
837 SPINAL COMPRESSION FRACTURE 50
838 URINARY TRACT DISORDER 50
839 ABDOMINAL ABSCESS 49
840 BLOOD PHOSPHORUS DECREASED 49
841 EARLY SATIETY 49
842 ERYTHEMA MULTIFORME 49
843 GINGIVAL SWELLING 49
844 INJECTION SITE MASS 49
845 LACTIC ACIDOSIS 49
846 MALIGNANT ASCITES 49
847 NEUROLOGICAL SYMPTOM 49
848 SARS-COV-2 TEST POSITIVE 49
849 TOXIC LEUKOENCEPHALOPATHY 49
850 AORTIC VALVE INCOMPETENCE 48
851 BEDRIDDEN 48
852 CHRONIC KIDNEY DISEASE 48
853 DYSKINESIA 48
854 GENERALISED TONIC-CLONIC SEIZURE 48
855 INTENTIONAL DOSE OMISSION 48
856 OCULAR ICTERUS 48
857 OESOPHAGEAL CARCINOMA 48
858 BREAST NEOPLASM 47
859 BURSITIS 47
860 DILATED CARDIOMYOPATHY 47
861 EJECTION FRACTION 47
862 NEUTROPHILIA 47
863 PELVIC ABSCESS 47
864 RALES 47
865 RASH PAPULAR 47
866 RECTAL TENESMUS 47
867 STATUS EPILEPTICUS 47
868 SUICIDAL IDEATION 47
869 TRANSFUSION 47
870 VASCULAR PAIN 47
871 ARTERIOSCLEROSIS 46
872 DERMATOMYOSITIS 46
873 DRUG EFFECT INCOMPLETE 46
874 EMPHYSEMA 46
875 LIP BLISTER 46
876 METASTASES TO EYE 46
877 NASAL MUCOSAL DISORDER 46
878 OBSTRUCTION 46
879 PETECHIAE 46
880 PLATELET COUNT ABNORMAL 46
881 PRODUCT ADMINISTRATION ERROR 46
882 PSYCHOLOGICAL TRAUMA 46
883 TUMOUR NECROSIS 46
884 ACUTE HEPATIC FAILURE 45
885 AORTIC ARTERIOSCLEROSIS 45
886 APHAGIA 45
887 APPETITE DISORDER 45
888 CHOLECYSTITIS ACUTE 45
889 CYSTITIS HAEMORRHAGIC 45
890 FLUID INTAKE REDUCED 45
891 GOUT 45
892 HAEMODYNAMIC INSTABILITY 45
893 HYPERTHYROIDISM 45
894 LOOSE TOOTH 45
895 NEUROLOGICAL DECOMPENSATION 45
896 PRODUCT DOSE OMISSION 45
897 RECTAL PERFORATION 45
898 STOMA SITE HAEMORRHAGE 45
899 TUBULOINTERSTITIAL NEPHRITIS 45
900 VENTRICULAR HYPOKINESIA 45
901 DRUG ADMINISTRATION ERROR 44
902 ELECTROCARDIOGRAM ABNORMAL 44
903 EOSINOPHIL COUNT INCREASED 44
904 HYPOPROTEINAEMIA 44
905 LACERATION 44
906 MUSCLE TIGHTNESS 44
907 MUSCULOSKELETAL DISCOMFORT 44
908 POOR QUALITY SLEEP 44
909 THROMBOPHLEBITIS 44
910 BONE MARROW DISORDER 43
911 CHAPPED LIPS 43
912 CREPITATIONS 43
913 DERMATITIS BULLOUS 43
914 DRY THROAT 43
915 FEMORAL NECK FRACTURE 43
916 HEMIANOPIA 43
917 INJECTION SITE EXTRAVASATION 43
918 POST PROCEDURAL HAEMORRHAGE 43
919 SINUS DISORDER 43
920 SKIN CANCER 43
921 ANAL FISTULA 42
922 BLOOD THYROID STIMULATING HORMONE INCREASED 42
923 BRAIN OPERATION 42
924 CARDIOVASCULAR DISORDER 42
925 DECREASED INTEREST 42
926 FEAR 42
927 FIBROSIS 42
928 HYPERNATRAEMIA 42
929 LARYNGEAL OEDEMA 42
930 LIP DRY 42
931 LIP PAIN 42
932 NODULAR REGENERATIVE HYPERPLASIA 42
933 PRODUCT PRESCRIBING ISSUE 42
934 PROTEIN TOTAL INCREASED 42
935 SHOCK HAEMORRHAGIC 42
936 SKIN INFECTION 42
937 SKIN NECROSIS 42
938 THERAPEUTIC RESPONSE UNEXPECTED 42
939 VOCAL CORD PARALYSIS 42
940 ABNORMAL FAECES 41
941 BLOOD TRIGLYCERIDES INCREASED 41
942 BONE CANCER 41
943 DRUG TOLERANCE DECREASED 41
944 ERYSIPELAS 41
945 FACIAL PARALYSIS 41
946 FEBRILE BONE MARROW APLASIA 41
947 FEMALE GENITAL TRACT FISTULA 41
948 GASTROINTESTINAL OBSTRUCTION 41
949 GROIN PAIN 41
950 HERNIA 41
951 INTESTINAL HAEMORRHAGE 41
952 KERATITIS 41
953 MOOD ALTERED 41
954 MYOPATHY 41
955 NERVOUSNESS 41
956 NOCTURIA 41
957 ONYCHALGIA 41
958 OVARIAN CYST 41
959 PHARYNGEAL INFLAMMATION 41
960 PNEUMOCYSTIS JIROVECII PNEUMONIA 41
961 PROTEIN URINE 41
962 QUALITY OF LIFE DECREASED 41
963 URINE ODOUR ABNORMAL 41
964 VEIN DISORDER 41
965 WOUND COMPLICATION 41
966 ABDOMINAL SEPSIS 40
967 ABDOMINAL TENDERNESS 40
968 AORTIC THROMBOSIS 40
969 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 40
970 GASTROENTERITIS VIRAL 40
971 GENE MUTATION 40
972 HEPATIC CANCER METASTATIC 40
973 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 40
974 PELVIC FRACTURE 40
975 PLEURITIC PAIN 40
976 PULMONARY CONGESTION 40
977 SCAR 40
978 SEASONAL ALLERGY 40
979 SKIN LACERATION 40
980 SUPRAVENTRICULAR TACHYCARDIA 40
981 UPPER LIMB FRACTURE 40
982 VENTRICULAR EXTRASYSTOLES 40
983 WHITE BLOOD CELL COUNT ABNORMAL 40
984 BLOOD PRESSURE SYSTOLIC DECREASED 39
985 GALLBLADDER DISORDER 39
986 GASTROENTERITIS RADIATION 39
987 GUILLAIN-BARRE SYNDROME 39
988 HYPERPYREXIA 39
989 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 39
990 MUCOSAL TOXICITY 39
991 PARAPARESIS 39
992 PARESIS 39
993 POOR VENOUS ACCESS 39
994 SCAB 39
995 SOFT TISSUE INFECTION 39
996 UTERINE LEIOMYOMA 39
997 ALANINE AMINOTRANSFERASE ABNORMAL 38
998 BRAIN FOG 38
999 BUNDLE BRANCH BLOCK LEFT 38